Using a mobile clinic to improve treatment for opioid addiction
Implementation of Contingency Management in a Mobile Low-Threshold Buprenorphine Clinic
['FUNDING_OTHER'] · UNIVERSITY OF ILLINOIS AT CHICAGO · NIH-11056876
This study is testing a new program that helps people with opioid addiction by providing support and medication through a mobile clinic, making it easier for those in need to get the help they deserve.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT CHICAGO (nih funded) |
| Locations | 1 site (Chicago, UNITED STATES) |
| Trial ID | NIH-11056876 on ClinicalTrials.gov |
What this research studies
This research focuses on implementing a contingency management program in a mobile clinic that provides low-threshold buprenorphine treatment for individuals with opioid use disorder. The approach aims to enhance access to effective behavioral health treatments alongside medication, addressing barriers that have previously limited the use of such interventions in community settings. By utilizing a mobile clinic, the research seeks to reach underserved populations and improve treatment outcomes for those struggling with addiction. The project will also involve training the principal investigator in implementation science and clinical trial design to ensure the program's effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with opioid use disorder who may benefit from low-threshold treatment options.
Not a fit: Patients who are not dealing with opioid use disorder or those who do not require medication-assisted treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective treatment for opioid addiction, potentially reducing overdose deaths.
How similar studies have performed: Previous research has shown that contingency management is effective in treating substance use disorders, indicating a strong potential for success in this adapted approach.
Where this research is happening
Chicago, UNITED STATES
- UNIVERSITY OF ILLINOIS AT CHICAGO — Chicago, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MESSMER, SARAH — UNIVERSITY OF ILLINOIS AT CHICAGO
- Study coordinator: MESSMER, SARAH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: addictive disorder